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ABSTRACT 
Introduction: We hypothesized that nutritional defi ciency would be common in a cohort of postpartum, human immunodefi ciency 
virus (HIV)-infected women and their infants. Methods: Weight and height, as well as blood concentrations of retinol, 
α-tocopherol, ferritin, hemoglobin, and zinc, were measured in mothers after delivery and in their infants at birth and at 6-12 
weeks and six months of age. Retinol and α-tocopherol levels were quantifi ed by high performance liquid chromatography, 
and zinc levels were measured by atomic absorption spectrophotometry. The maternal body mass index during pregnancy was 
adjusted for gestational age (adjBMI). Results: Among the 97 women 19.6% were underweight. Laboratory abnormalities were 
most frequently observed for the hemoglobin (46.4%), zinc (41.1%), retinol (12.5%) and ferritin (6.5%) levels. Five percent 
of the women had mean corpuscular hemoglobin concentrations < 31g/dL. The most common defi ciency in the infants was 
α-tocopherol (81%) at birth; however, only 18.5% of infants had defi cient levels at six months of age. Large percentages of 
infants had zinc (36.8%) and retinol (29.5%) defi ciencies at birth; however, these percentages decreased to 17.5% and 18.5%, 
respectively, by six months of age. No associations between infant micronutrient defi ciencies and either the maternal adjBMI 
category or maternal micronutrient defi ciencies were found. Conclusions: Micronutrient defi ciencies were common in HIV-
infected women and their infants. Micronutrient defi ciencies were less prevalent in the infants at six months of age. Neither 
underweight women nor their infants at birth were at increased risk for micronutrient defi ciencies.
Keywords: Micronutrients. HIV infection. Pregnancy. Infant. Nutrition. Cohort.
Maternal malnutrition is associated with increased risks 
of infant morbidity and mortality1. Multiple micronutrient 
defi ciencies may develop in pregnant women early during 
human immunodefi ciency virus type 1 (HIV-1) infection2,3. 
Zinc defi ciency, which is common in HIV-infected individuals, 
has been associated with higher mortality and viral load4,5. 
Zinc supplementation during pregnancy results in improved 
neonatal immune status, reduced early neonatal morbidity 
and fewer infant infections6. Pregnancy increases the risk of 
vitamin A defi ciency in mothers and newborns. Randomized 
trials of vitamin A supplementation in pregnant women found 
decreased mortality and a reduced prevalence and duration of 
infectious episodes in infants7. In a Brazilian study, maternal 
vitamin A defi ciency was strongly associated with infant vitamin 
A defi ciency and low birth weight8. Brazilian HIV-infected 
pregnant women may have low vitamin A levels even after 
supplementation9. 
HIV infection and pregnancy are accompanied by oxidative 
stress. Lower levels of vitamin E may play a pathogenic role 
in the onset and development of acquired immunodefi ciency 
syndrome (AIDS) and other infectious diseases10,11. Several 
studies have revealed lower vitamin E levels in HIV-infected 
children in Brazil and elsewhere12-14. Among healthy pregnant 
women, infant birth weight and length are associated with 
maternal serum concentrations of antioxidant vitamins15. 
Anemia is the most frequent hematologic abnormality found in 
HIV disease16. Standard prenatal care for HIV-infected pregnant 
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METHODS
women in Latin America includes iron and folate supplements 
to prevent anemia and neural tube defects. 
We hypothesized that nutritional defi ciency is frequent 
among HIV-infected mothers and their infants in Brazil. Our 
objectives were as follows: 1) to describe the nutritional status 
of HIV-infected women at delivery and of their infants at sites 
in Brazil based on anthropometric measurements, including 
the maternal adjusted for gestational age (adjBMI), and on 
plasma micronutrient concentrations; 2) to assess the correlation 
between maternal and infant micronutrient levels at delivery; 
and 3) to evaluate changes in the micronutrient status of infants 
from birth to six months of age.
The LILAC study
HIV-infected pregnant women enrolled at three participating 
Brazilian sites in the Eunice Kennedy Shriver National Institute of 
Child Health and Human Development (NICHD), International 
Site Development Initiative (NISDI) and Longitudinal Study in 
Latin American Countries (LILAC) dynamic cohort were invited 
to participate in this nutritional LILAC sub-study. The design 
and conduct of the LILAC study has been described previously17.
Nutritional Sub-study
This nutritional sub-study enrolled LILAC participants at three 
study sites in Brazil. The protocol for this sub-study was approved 
by the Institutional Review Boards (IRBs) of the participating 
institutions. This sub-study required the collection of additional 
blood from mothers (within seven days of delivery) and infants 
(at birth and then at the 6-12-week and 6-month study visits) for 
the analysis of micronutrient levels (retinol, α-tocopherol, ferritin, 
and zinc). The blood samples were stored at -70°C in the dark 
until processing. Plasma retinol and α-tocopherol concentrations 
were quantifi ed by high performance liquid chromatography 
(HPLC) as previously described18. Serum zinc was determined by 
atomic absorption spectrophotometry using standard procedures19. 
Maternal C-reactive protein (CRP) levels were quantifi ed to 
characterize infl ammation. CRP and ferritin were measured in 
plasma samples using immunoassay technology (Immulite 1,000 
Immunoassay System - Global Siemens Healthcare Headquarters 
- Siemens AG; Henkestrasse 127; D-91052 Erlangen - Germany).
The maternal body mass index (BMI) at the last study visit 
during pregnancy was adjusted for gestational age (adjBMI) 
using a computer algorithm provided by the Ministry of 
Health of Argentina20 and was used as a criteria for nutritional 
status classifi cation. Maternal adjBMI values that were <19.8 
were considered underweight, ≥26.1 to <29 were considered 
overweight, and ≥29 to <50 were classifi ed as obese. Maternal 
and infant micronutrient status was defi ned at each time point 
as deficient vs. normal for each micronutrient measured. 
Defi ciencies were defi ned as follows for each micronutrient: 
zinc level, <64mg/dL for infants and <50mg/dL for mothers21; 
retinol level, <0.7mmol/L for both infants and mothers22; 
α-tocopherol level, <12mmol/L for infants and <7mmol/L for 
mothers23; and ferritin level, <10ng/mL for mothers, <25ng/mL 
for infants less than one month of age, <200ng/mL for infants 
one to two months of age, <50ng/mL for infants aged two months 
to less than six months, and <7ng/mL for ages six months to 
15 years24. The cut-off values for C-reactive protein (CRP) 
categories in pregnant women were as follows: low, < 1mg/dL; 
normal, 1-3mg/dL; high, >3mg/dL25. Infant CRP cut-off values 
were as follows: normal, ≤0.5mg/dL; high, >0.5mg/dL26. HIV 
disease was classifi ed according to the Centers for Disease Control 
and Prevention (CDC) defi nitions27. A low mean corpuscular 
hemoglobin concentration (MCHC) level was defi ned as <31g/
dL for pregnant women and for infants24. The cut-off values 
for hemoglobin in pregnant women were as follows: severe 
deficiency, 6.5-7.4g/dL; low, 7.5-8.4g/dL; mild deficiency, 
8.5-10g/dL; and normal, >10g/dL28. The normal hemoglobin range 
for infants was adjusted for age: one to three days, 14.5-18.5g/
dL; two weeks, 13.4-16.6g/dL; one month, 10.7-13.9g/dL; two 
months, 9.4-11g/dL; and from two to six months, 11.1-12.6g/dL28.
Maternal antiretroviral (ARV) regimens were categorized 
in order of regimen complexity as follows: 1) one or two 
nucleoside reverse transcriptase inhibitors (NRTIs), 2) two 
NRTIs and one non-nucleoside reverse transcriptase inhibitor 
(NNRTI), 3) two NRTIs and one protease inhibitor (PI), 
and 4) other. The reason for the use of ARVs during pregnancy 
was categorized as treatment if ARVs were used before 
pregnancy and/or continued after the 6-12-week study visit, or 
as prophylaxis if ARVs were initiated during pregnancy and use 
was discontinued by the 6-12-week visit.
Statistical analysis
Associations between maternal adjBMI values and 
the following characteristics of mothers and infants were 
examined: maternal age at enrollment, maternal years of formal 
education, number of persons in the household, mother’s 
gainful employment outside the home, substance use during 
pregnancy, reasons for ARV use during pregnancy, maternal 
ARV regimen, maternal cluster of differentiation 4 (CD4) + 
T-lymphocyte (CD4) count, plasma Human immunodefi ciency 
virus-ribonucleic acid (HIV-RNA) concentration [viral 
load(VL)], CDC clinical HIV disease classifi cation27, gestational 
hypertension, gestational diabetes, preterm birth (<37 weeks of 
gestational age)1, low infant birth weight (<2,500g)1, infant ARV 
regimen and CD4+ T-lymphocyte count at birth. Associations 
between maternal adjBMI and maternal and infant micronutrient 
levels, which were categorized as defi cient vs. normal, were 
examined. Additionally, associations between micronutrient 
levels in mothers and infants were examined. The maternal 
vitamin A, vitamin E, iron, and zinc levels were examined 
within seven days of delivery, and infant micronutrient status 
was examined at birth, 6-12 weeks, and six months of age. 
These associations were examined using Fisher’s exact test 
or the Fisher-Freemen-Halton extension to Fisher’s exact test. 
Signifi cant bivariate results were further investigated on the 
basis of relative risks (RRs) and 95% confi dence intervals 
(95% CIs) were obtained from log-binomial regression modeling. 
Linear regression and one-way analysis of variance (ANOVA) 
were used to examine associations between continuous maternal 
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TABLE 1 - Characteristics of 97 mother-infant pairs by maternal adjBMI. 
                         Maternal adjBMI  
                    overweight/obese  normal        underweight         total
Characteristics n=26 % n=52 % n=19 % n=97 % p-value*
Maternal characteristics
Age at enrollment (years)         0.17
<20  0 0.0 6 11.5 2 10.5 8 8.2 
20-29  18 69.2 24 46.2 8 42.1 50 51.5 
>29  8 30.8 22 42.3 9 47.4 39 40.2 
Reason for use of ARVs during pregnancy         0.03
prophylaxis 15 62.5 20 38.5 6 31.6 41 43.2 
treatment 9 37.5 32 61.5 13 68.4 54  56.8 
unknown             2                        0                        0                         2  
Most complex ARV regimen used >28 days of pregnancy         0.37
none 1 4.0 0 0.0 0 0.0 1 1.1 
1-2 NRTIs 0 0.0 0 0.0 1 5.6 1 1.1  
2 NRTIs and 1 PI 19 76.0 39 79.6 16 88.9 74 80.4 
2 NRTIs and 1 NNRTI 3 12.0  8 16.3 1 5.6 12 13.0 
other regimen 2 8.0 2 4.1 0 0.0 4 4.3 
missing              1                        3                       1                          5 
CD4 count (cells/mm3) at enrollment         0.09
<200  2 7.7  2 3.8 5 26.3 9 9.3 
200-499  9 34.6 22 42.3 7 36.8 38 39.2 
≥500  15 57.7 28 53.8 7 36.8 50 51.5 
Viral load (copies/mL) at enrollment         0.09
<1,000  18 69.2 42 80.8 11 57.9 71 73.2 
1,000-9,999  3 11.5 2 3.8 5 26.3  10 10.3 
≥10,000  5 19.2 8 15.4 3 15.8 16 16.5 
CDC disease stage at enrollment         0.53
A 23 88.5 37 71.2 16 84.2 76 78.4 
B 2 7.7 8 15.4 2 10.5 12 12.4 
C (AIDS) 1 3.8 7 13.5 1 5.3 9 9.3 
*Fisher’s exact test. adjBMI: body mass index adjusted for gestational age; ARV: antiretroviral; NRTI: nucleoside reverse transcriptase 
inhibitors; PI: protease inhibitor; NNRTI: non-nucleoside reverse transcriptase inhibitor; CD4: cluster of differentiation 4; CDC: Centers for 
Disease Control and Prevention.
and infant nutritional variables at the study time points. All 
p-values were two-sided. The p-values<0.05 were considered 
statistically signifi cant. Analyses were conducted using SAS 
version 9.3 statistical software (SAS Institute, Cary, NC, USA).
In total, 123 women that were enrolled in the LILAC 
protocol at the participating sites provided informed consent to 
participate in this sub-study, and blood samples were available 
for 97 mother-infant pairs. Thus, the study population was 
composed of 97 mother-infant pairs. All infants were HIV-
uninfected.
The characteristics of the 97 mother-infant pairs overall 
and according to maternal adjBMI at the last study visit 
during pregnancy are shown in Table 1. Based on the adjBMI 
measurements, 26 (26.8%) of the mothers were classifi ed 
as overweight/obese, 52 (53.6%) were normal weight, and 
19 (19.6%) were underweight. The reason for using ARVs 
during pregnancy was signifi cantly associated with adjBMI 
(p-value=0.03); a higher proportion of overweight/obese women 
received ARVs for prophylaxis (as opposed to treatment) during 




































































   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   







   











   














   
   















































































































































































































































































































































































































































































































































pregnancy compared with normal weight or underweight 
women. No associations were observed between maternal 
adjBMI and years of education (p-value=0.45), the number of 
persons in the household (p-value=0.41), gainful employment 
outside the home (p-value=0.54), tobacco use during pregnancy 
(p-value=0.74), alcohol use during pregnancy (p-value=0.71), 
cocaine use during pregnancy (p-value=0.42) or marijuana 
use during pregnancy (p-value=0.42). Additionally, maternal 
adjBMI was not associated with preterm birth (p-value=0.77), 
low birth weight (p-value=0.28) or infant CD4 count at birth 
(p-value=0.59). The median gestational age at the time of 
adjBMI assessment was 33 weeks (minimum, 25 weeks; 
maximum, 39 weeks). Underweight women were signifi cantly 
more likely to have low MCHC after delivery than their normal 
and overweight counterparts (p-value<0.01; data not shown). 
Nutritional and infl ammatory marker data for the mothers 
and infants are summarized [mean, standard deviation (SD)], 
median, and range) in Table 2. The test results are categorized as 
normal versus defi cient in Table 3. The most frequent maternal 
defi ciencies were zinc (41.1%), followed by retinol (12.5%), 
ferritin (6.5%) and α-tocopherol (1%) (Table 3). Additionally, 
46.4% of the women had low hemoglobin levels, and the 
MCHC was <31g/dL in 5.2% of the women. Approximately 
54% of the women had high levels of CRP in their blood at 
hospital discharge following delivery. At birth, 81.1% of the 
infants were defi cient in α-tocopherol, with the proportion 
decreasing with age to only 18.5% by six months of age. 
High proportions of neonates also had defi cient levels of zinc 
(36.8%) and retinol (29.5%) at birth, and these numbers fell 
to only 17.5% and 18.5%, respectively, by six months of age. 
The proportion of infants with low levels of retinol increased to 
41.1% by 6-12 weeks of age before decreasing by six months 
of age. Although none of the infants had low ferritin levels at 
birth, a sharp increase was observed in the proportion of infants 
with low ferritin levels at 6-12 weeks of age (58.7%) and at 
6 months of age (25.8%). Additionally, low hemoglobin levels 
were observed in 43.8% and 7.5% of the infants at 6-12 weeks 
of age and at 6 months of age, respectively. All infants were 
formula-fed after birth.
When we compared the underweight adjBMI category 
with the normal adjBMI category, no association was found 
between maternal underweight adjBMI during pregnancy and 
maternal zinc (RR=1.2, 95% CI: 0.7, 2.3), retinol (RR=0.7, 95% 
CI: 0.2, 2.9), α-tocopherol (RR not calculable), or ferritin 
(RR=1.4, 95% CI: 0.5, 4.4) defi ciency at delivery, nor was any 
observed association found between maternal underweight 
adjBMI during pregnancy and infant zinc (RR=0.9, 95% 
CI: 0.4, 1.9), retinol (RR=0.6, 95% CI: 0.2, 1.7), α-tocopherol 
(RR=0.9, 95% CI: 0.6, 1.2), ferritin (RR=0.7, 95% CI: 0.4, 1.3), 
or MCHC at birth (RR=2.7, 95% CI: 0.2, 41.6; Table 4). In 
addition, maternal zinc, α-tocopherol, ferritin, and retinol 
defi ciencies were not associated with age, years of education, 
the number of persons in the household, gainful employment 
outside the home, tobacco use during pregnancy, alcohol use 
during pregnancy, cocaine use during pregnancy, marijuana 
use during pregnancy, preterm birth, low birth weight or 
infant CD4 count at birth (data not shown). Women with 
Monteiro JP et al. - Micronutrient status in HIV-infected mothers and their uninfected infants
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TABLE 3 - Nutritional and infl ammatory parameters (as categorical variables) among women (after delivery) and infants (at study visits).
                Infants
             Category                 Mothers                         at birth                    6-12 weeks        6 months
Parameter  n=97 % n=97 % n=97 % n=97 %
Zinc (mg/dL) normal  56 59.0 55 63.2 34 75.6 33 82.5
 defi cient  39 41.1 32 36.8 11 24.4 7 17.5
 missing                   2                                   10                                  52                              57
Retinol (μmol/L) normal  84 87.5 67 70.5 56 59.0 75 81.5
 defi cient 12 12.5 28 29.5 39 41.1 17 18.5
 missing                  1                                    2                                     2                                5
α-Tocopherol (μmol/L) normal 95 99.0 18 19.0 70 73.7 75 81.5
 defi cient 1 1.0 77 81.1 25 26.3 17 18.5
 missing                   1                                    2                                     2                                5
Ferritin (ng/mL) low 6 6.5                  0  54 58.7 16 25.8
 normal 77 83.7  38 44.7 34 37.0 45 72.6
 high  9 9.8 47 55.3 4 4.4 1 1.6
 missing                  5                                    12                                  5                                35
MCHC (g/dL) missing                  0                                     0                                   1                          4
 normal 92 94.9 93 95.9 92 95.8 90 96.8
 defi cient 5 5.2  4 4.1 4 4.2 3 3.2
Age-adjusted hemoglobin (g/dL) normal 52 53.6 77 79.4 54 56.3 86 92.5
 low 45 46.4 20 20.6 42 43.8 7 7.5
 missing                  0                                     0                                   1                                 4
C-reactive protein (mg/dL) low 18 18.6 0 0.0 0 0.0  0 0.0
 normal 27 27.8 77 81.1 83 90.2 79 86.8
 high 52 53.6 18 18.9 9 9.8 12 13.2
 missing                   0                                    2                                    5                                 6
MCHC: mean corpuscular hemoglobin concentration.
acquired immunodefi ciency syndrome (AIDS) were less likely 
to have normal retinol levels than women with asymptomatic or 
mildly symptomatic HIV disease (RR=0.2, 95% CI: 0.1, 0.6; data 
not shown). Low maternal hemoglobin was associated only with 
low maternal CD4+ T-lymphocyte counts at enrollment. Women 
who had CD4 cell counts that were <200 cells/mm3 were less 
likely to have normal hemoglobin levels than were women with 
CD4+ T-lymphocyte counts that were ≥ 500 cells/mm3 (RR=0.4, 
95% CI: 0.3, 0.7; data not shown). Low maternal zinc, ferritin, 
and hemoglobin were not associated with elevated maternal CRP 
(p-value>0.8). No observed associations were found between low 
maternal levels of zinc (RR=1.0, 95%CI: 0.6, 1.7), retinol (RR=1.5, 
95%CI: 0.7, 3.2), α-tocopherol (RR not calculable), or ferritin 
(RR=0.9, 95%CI: 0.5, 1.6) after delivery and corresponding low 
levels of these micronutrients in the infants at birth (p-value>0.3; 
Table 5). Additionally, linear regression analysis did not reveal 
any signifi cant associations between maternal and infant zinc, 
retinol, α-tocopherol, or ferritin levels at birth when the levels were 
examined on a continuous scale (p-value>0.15).
No observed associations were found between low infant 
zinc, retinol or α-tocopherol levels at birth and low levels 
of the same micronutrients at 6-12 weeks or at six months 
of age (p-value>0.1). Low infant ferritin levels at birth were 
associated with normal infant ferritin levels at 6-12 weeks 
of age (p-value=0.04). This association persisted but was 
only marginally associated with levels at six months of age 
(p-value=0.07). Overall, a slightly lower proportion of infants 
had micronutrient defi ciencies at the six-month visit than at 
birth (data not shown).
Rev Soc Bras Med Trop 47(6):692-700, Nov-Dec, 2014
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TABLE 4 - Association between maternal adjusted BMI (adjBMI) and micronutrient levels. 
                RR (95% CI)* for maternal adjBMI
                Maternal adjusted BMI                                                                                overweight/
       obese vs
Micronutrient overweight/obese normal underweight total p-value** underweight vs normal normal
Maternal micronutrient levels
Zinc     0.76  
defi cient  11 (42.3%) 19 (38.0%) 9 (47.4%)  39 (41.1%)  1.2 (0.7, 2.3) 1.1 (0.6, 2.0)
normal 15 (57.7%) 31 (62.0%) 10 (52.6%) 56 (58.9%)  1.0
Retinol     0.71  
defi cient  2 (7.7%) 8 (15.7%) 2 (10.5%)  12 (12.5%)  0.7 (0.2, 2.9) 0.5 (0.1, 2.1)
normal 24 (92.3%) 43 (84.3%) 17 (89.5%) 84 (87.5%)  1.0
α-Tocopherol     0.47  
defi cient  1 (3.8%) 0 (0.0%) 0 (0.0%) 1 (1.0%)  NC NC
normal 25 (96.2%) 51 (100.0%) 19 (100.0%) 95 (99.0%)
Ferritin     0.76  
defi cient  4 (16.0%) 7 (14.6%) 4 (21.1%) 15 (16.3%)  1.4 (0.5, 4.4) 1.1 (0.4, 3.4)
normal 21 (84.0%) 41 (85.4%) 15 (78.9%) 77 (83.7%)  1.0
Infant micronutrient levels at birth
Zinc     0.58  
defi cient  7 (28.0%) 19 (41.3%) 6 (37.5%) 32 (36.8%)  0.9 (0.4, 1.9) 0.7 (0.3, 1.4)
normal 18 (72.0%) 27 (58.7%) 10 (62.5%) 55 (63.2%)  1.0
Retinol     0.31  
defi cient  10 (38.5%) 15 (29.4%) 3 (16.7%) 28 (29.5%)  0.6 (0.2, 1.7) 1.3 (0.7, 2.5)
normal 16 (61.5%) 36 (70.6%) 15 (83.3%) 67 (70.5%)  1.0
α-Tocopherol     0.50  
defi cient  21 (80.8%) 43 (84.3%) 13 (72.2%) 77 (81.1%)  0.9 (0.6, 1.2) 1.0 (0.8, 1.2)
normal 5 (19.2%) 8 (15.7%) 5 (27.8%) 18 (18.9%)  1.0
Ferritin     0.23  
defi cient  9 (42.9%) 30 (63.8%) 8 (47.1%) 47 (55.3%)  0.7 (0.4, 1.3) 0.7 (0.4, 1.2)
normal 12 (57.1%) 17 (36.2%) 9 (52.9%) 38 (44.7%)  1.0
MCHC     0.42  
defi cient  0 (0.0%) 1 (1.9%)  1 (5.3%) 2 (2.1%)  2.7 (0.2, 41.6) NC
normal 26 (100.0%) 51 (98.1%) 18 (94.7%) 95 (97.9%)  1.0 
*The relative risks (RRs) and 95% confi dence intervals (CIs) for predicting maternal and infant micronutrient defi ciencies as a function 
of maternal adjBMI were obtained using log binomial regression models.**p-values were obtained using the Fisher-Freeman-Halton test. 
NC: value could not be calculated; adjBMI: body mass index adjusted for gestational age; MCHC: mean corpuscular hemoglobin concentration.
Monteiro JP et al. - Micronutrient status in HIV-infected mothers and their uninfected infants
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TABLE 5 - Association between maternal and infant micronutrient levels. 
       Maternal micronutrient level  
Infant micronutrient defi cient normal total p-value* RR (95% CI)
Zinc    1.00 1.0 (0.6, 1.7)
defi cient  22 (62.7%) 32 (62.7%) 54 (62.8%)
normal 13 (37.1%) 19 (37.2%) 32 (37.2%)
Retinol    0.33 1.5 (0.7, 3.2)
defi cient  7 (58.3%) 59 (72.0%) 66 (70.2%)
normal 5 (41.7%) 23 (28.0%) 28 (29.8%)
α-Tocopherol    1.00 NC
defi cient  0 (0.0%) 18 (19.3%) 18 (19.1%)
normal 1 (100.0%) 75 (80.7%) 76 (80.9%)
Ferritin    0.76 0.9 (0.5, 1.6)
defi cient  6 (50.0%) 30 (44.1%) 36 (45.0%)
normal 6 (50.0%) 38 (55.9%) 44 (55.0%)
*The p-values were obtained using Fisher’s exact test.  NC: value could not be calculated. RR: relative risk; CI: Confi dence interval.
DISCUSSION
Micronutrient defi ciencies are common in HIV-infected 
pregnant women and their infants in Brazil. The prevalences 
of most infant micronutrient defi ciencies were lower at six 
months of age than at birth. Being underweight at the end of 
pregnancy was not associated with micronutrient defi ciency in 
HIV-infected women or their infants at birth.
We found that 46.4% of HIV-infected mothers were 
anemic and that 6.5% had low levels of ferritin immediately 
postpartum. Few studies have reported iron defi ciency in HIV-
infected pregnant women in Latin America; however, some 
studies have reported an extremely high prevalence of anemia 
in HIV-infected pregnant women in other countries28; 78% of 
HIV-infected pregnant women in Burkina Faso were reported 
to be anemic29, and 83% of HIV-infected pregnant women in 
Cote d’Ivoire were reported to be anemic30.
Factors such as poor nutritional status, HIV infection31, ARV 
therapy32, and even vitamin D defi ciency33 could explain the high 
prevalence of anemia found in the present sub-study. However, 
the acute phase response34 was not associated with anemia. Few 
studies have examined lipid-soluble vitamins in HIV-infected 
pregnant women35–37. In Tanzania38, approximately 35 and 51% 
of HIV-infected pregnant women had low levels of vitamins A 
and E, respectively. In contrast, only 12.5 and 1% of women in 
our sub-study had vitamin A and E defi ciencies, respectively, 
although our cut-off for vitamin E defi ciency was lower than that 
used in Tanzania38 (vitamin E level<9.7 μmol/L). Zinc defi ciency 
has been reported in children39 and in HIV-infected individuals5,40 
and is thought to be widely prevalent in pregnant women due to 
hemodilution, decreased albumin levels and insuffi cient intake41-43. 
Infants in our sub-study had lower rates of micronutrient 
defi ciencies and higher mean levels of vitamin A and vitamin E 
than those found by Monteiro et al. in a group of HIV-infected 
Latin American children14. Nevertheless, 81% of infants at 
birth were defi cient in α-tocopherol, which could partially 
be explained by increased oxidative stress during delivery. 
Increased levels of oxidative stress and lipid peroxidation 
induced by reactive oxygen species (ROS) production play 
a critical role in the stimulation of HIV replication and 
immunodefi ciency and can be attenuated by the presence of 
vitamin E44. However, vitamin E may facilitate HIV entry into 
cells, and higher plasma vitamin E levels have been associated 
with adverse outcomes in HIV-infected individuals45. Thus, 
lower vitamin E levels may constitute a physiological defense 
mechanism against HIV in infants during delivery.
A high proportion of infants (41%) had vitamin A defi ciency 
at 6 to 12 weeks, with mean and SD values of 0.8 and 0.4μmol/L, 
respectively. Chatterjee A et al. also found vitamin A defi ciency 
at six weeks of age; The percentages of infants with plasma 
vitamin A concentrations less than 0.70mmol/L or 0.35mmol/L 
were 89% and 22%, respectively, in this sub-study46. These 
authors found that higher vitamin A concentrations in plasma 
at six weeks of age were protective against mortality in children 
born to HIV-infected women.
Our sub-study had several limitations. Vitamin A defi ciency 
in this sub-study was defi ned based on WHO recommendations, 
which are widely accepted and used28; however, no consensus 
regarding a defi nition of vitamin E defi ciency exists. Maternal 
adjBMI during pregnancy, which is used as a measure of 
maternal nutritional status, may not actually be a good surrogate 
for nutritional assessment. Additionally, maternal specimens 
collected up to seven days postpartum may not accurately 
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represent nutritional defi ciencies during pregnancy. We did 
not measure serum lipoprotein and cholesterol, which may be 
important because serum α-tocopherol (vitamin E) concentrations 
are highly dependent on serum lipid concentrations2,3. Likewise, 
this sub-study did not account for the dietary intake of 
vitamin A, vitamin E, iron or zinc. All infants were formula-fed 
and thus received at least some supplementation after birth, 
although the exact amounts of supplementation are not known. 
Moreover, the interpretation of serum micronutrient levels is 
not straightforward due to the wide range of unknown nutrient-
nutrient and gene-nutrient interactions and physiological and 
environmental processes involved. 
The present sub-study suggests that low serum micronutrient 
levels are frequently found in HIV-infected pregnant women 
and their infants and that neither underweight women nor 
their infants at birth were at increased risk for low serum 
micronutrient levels. Future studies in different countries that 
have appropriate designs and that examine genetic and proteomic 
profi les should be pursued to gain a greater understanding of 
the interactions among genes, nutrients, and the environment 
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